LI
CLVS

Leap Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

Leap Investments’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,600
Closed -$67K – 621
2020
Q1 		$67K Sell
10,600
-135,700
-93% -$1.09M 0.1% 309
2019
Q4 		$1.52M Buy
+146,300
New +$1.06M 0.72% 23

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Leap Investments's CLVS Position: Q2 2020 in Review

Leap Investments sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 10,600 shares — an estimated $67K sold.

Leap Investments first reported a position in CLVS in Q4 2019 and held it in 2 quarters. The position peaked at $1.52M in Q4 2019. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Leap Investments reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Leap Investments sold 10,600 Clovis Oncology, Inc. shares in Q2 2020, an estimated $67K.
  • Leap Investments first reported a position in Clovis Oncology, Inc. in Q4 2019 and held it in 2 quarters.
  • Leap Investments's Clovis Oncology, Inc. position peaked at $1.52M in Q4 2019.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.